BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 38672565)

  • 1. Interleukin-6 Family of Cytokines in Cancers.
    Zaporowska-Stachowiak I; Springer M; Stachowiak K; Oduah M; Sopata M; Wieczorowska-Tobis K; Bryl W
    J Interferon Cytokine Res; 2024 Feb; 44(2):45-59. PubMed ID: 38232478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promising systemic immunotherapies in head and neck squamous cell carcinoma.
    Gildener-Leapman N; Ferris RL; Bauman JE
    Oral Oncol; 2013 Dec; 49(12):1089-96. PubMed ID: 24126223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma IL-1 and IL-6 Family Cytokines with Soluble Receptor Levels at Diagnosis in Head and Neck Squamous Cell Carcinoma: High Levels Predict Decreased Five-Year Disease-Specific and Overall Survival.
    Aarstad HH; Moe SEE; Lybak S; Bruserud Ø; Tvedt THA; Aarstad HJ
    Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Acute Phase Reaction and Its Prognostic Impact in Patients with Head and Neck Squamous Cell Carcinoma: Single Biomarkers Including C-Reactive Protein Versus Biomarker Profiles.
    Aarstad HH; Moe SEE; Bruserud Ø; Lybak S; Aarstad HJ; Tvedt THA
    Biomedicines; 2020 Oct; 8(10):. PubMed ID: 33066437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognosis of HPV-associated metastatic pharyngeal patients by primary and distant site.
    Wang J; Tian Y; Huang H; Huang D; Liu Y; Tian Y; Zhu G; Zhang X; Ferris RL
    Oral Oncol; 2022 Feb; 125():105675. PubMed ID: 34968864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of immune makers with HPV 16 infections and the prognosis in oropharyngeal squamous cell carcinoma.
    Zhu Y; Zhu X; Diao W; Liang Z; Gao Z; Chen X
    Clin Oral Investig; 2023 Apr; 27(4):1423-1433. PubMed ID: 36884083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune checkpoint blockade induced shifts in cytokine expression patterns in peripheral blood of head and neck cancer patients are linked to outcome.
    Röhl L; Wellhausen J; Berszin M; Krücken I; Zebralla V; Pirlich M; Wiegand S; Dietz A; Wald T; Wichmann G
    Front Immunol; 2023; 14():1237623. PubMed ID: 37849764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGF-1R expression is associated with HPV-negative status and adverse survival in head and neck squamous cell cancer.
    Dale OT; Aleksic T; Shah KA; Han C; Mehanna H; Rapozo DC; Sheard JD; Goodyear P; Upile NS; Robinson M; Jones TM; Winter S; Macaulay VM
    Carcinogenesis; 2015 Jun; 36(6):648-55. PubMed ID: 25896444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonspecific Inhibition of IL6 Family Cytokine Signalling by Soluble gp130.
    Widjaja AA; Cook SA
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Global, Regional, and National Burden of Adult Lip, Oral, and Pharyngeal Cancer in 204 Countries and Territories: A Systematic Analysis for the Global Burden of Disease Study 2019.
    ; Cunha ARD; Compton K; Xu R; Mishra R; Drangsholt MT; Antunes JLF; Kerr AR; Acheson AR; Lu D; Wallace LE; Kocarnik JM; Fu W; Dean FE; Pennini A; Henrikson HJ; Alam T; Ababneh E; Abd-Elsalam S; Abdoun M; Abidi H; Abubaker Ali H; Abu-Gharbieh E; Adane TD; Addo IY; Ahmad A; Ahmad S; Ahmed Rashid T; Akonde M; Al Hamad H; Alahdab F; Alimohamadi Y; Alipour V; Al-Maweri SA; Alsharif U; Ansari-Moghaddam A; Anwar SL; Anyasodor AE; Arabloo J; Aravkin AY; Aruleba RT; Asaad M; Ashraf T; Athari SS; Attia S; Azadnajafabad S; Azangou-Khyavy M; Badar M; Baghcheghi N; Banach M; Bardhan M; Barqawi HJ; Bashir NZ; Bashiri A; Benzian H; Bernabe E; Bhagat DS; Bhojaraja VS; Bjørge T; Bouaoud S; Braithwaite D; Briko NI; Calina D; Carreras G; Chakraborty PA; Chattu VK; Chaurasia A; Chen MX; Cho WCS; Chu DT; Chukwu IS; Chung E; Cruz-Martins N; Dadras O; Dai X; Dandona L; Dandona R; Daneshpajouhnejad P; Darvishi Cheshmeh Soltani R; Darwesh AM; Debela SA; Derbew Molla M; Dessalegn FN; Dianati-Nasab M; Digesa LE; Dixit SG; Dixit A; Djalalinia S; El Sayed I; El Tantawi M; Enyew DB; Erku DA; Ezzeddini R; Fagbamigbe AF; Falzone L; Fetensa G; Fukumoto T; Gaewkhiew P; Gallus S; Gebrehiwot M; Ghashghaee A; Gill PS; Golechha M; Goleij P; Gomez RS; Gorini G; Guimaraes ALS; Gupta B; Gupta S; Gupta VB; Gupta VK; Haj-Mirzaian A; Halboub ES; Halwani R; Hanif A; Hariyani N; Harorani M; Hasani H; Hassan AM; Hassanipour S; Hassen MB; Hay SI; Hayat K; Herrera-Serna BY; Holla R; Horita N; Hosseinzadeh M; Hussain S; Ilesanmi OS; Ilic IM; Ilic MD; Isola G; Jaiswal A; Jani CT; Javaheri T; Jayarajah U; Jayaram S; Joseph N; Kadashetti V; Kandaswamy E; Karanth SD; Karaye IM; Kauppila JH; Kaur H; Keykhaei M; Khader YS; Khajuria H; Khanali J; Khatib MN; Khayat Kashani HR; Khazeei Tabari MA; Kim MS; Kompani F; Koohestani HR; Kumar GA; Kurmi OP; La Vecchia C; Lal DK; Landires I; Lasrado S; Ledda C; Lee YH; Libra M; Lim SS; Listl S; Lopukhov PD; Mafi AR; Mahumud RA; Malik AA; Mathur MR; Maulud SQ; Meena JK; Mehrabi Nasab E; Mestrovic T; Mirfakhraie R; Misganaw A; Misra S; Mithra P; Mohammad Y; Mohammadi M; Mohammadi E; Mokdad AH; Moni MA; Moraga P; Morrison SD; Mozaffari HR; Mubarik S; Murray CJL; Nair TS; Narasimha Swamy S; Narayana AI; Nassereldine H; Natto ZS; Nayak BP; Negru SM; Nggada HA; Nouraei H; Nuñez-Samudio V; Oancea B; Olagunju AT; Omar Bali A; Padron-Monedero A; Padubidri JR; Pandey A; Pardhan S; Patel J; Pezzani R; Piracha ZZ; Rabiee N; Radhakrishnan V; Radhakrishnan RA; Rahmani AM; Rahmanian V; Rao CR; Rao SJ; Rath GK; Rawaf DL; Rawaf S; Rawassizadeh R; Razeghinia MS; Rezaei N; Rezaei N; Rezaei N; Rezapour A; Riad A; Roberts TJ; Romero-Rodríguez E; Roshandel G; S M; S N C; Saddik B; Saeb MR; Saeed U; Safaei M; Sahebazzamani M; Sahebkar A; Salek Farrokhi A; Samy AM; Santric-Milicevic MM; Sathian B; Satpathy M; Šekerija M; Senthilkumaran S; Seylani A; Shafaat O; Shahsavari HR; Shamsoddin E; Sharew MM; Sharifi-Rad J; Shetty JK; Shivakumar KM; Shobeiri P; Shorofi SA; Shrestha S; Siddappa Malleshappa SK; Singh P; Singh JA; Singh G; Sinha DN; Solomon Y; Suleman M; Suliankatchi Abdulkader R; Taheri Abkenar Y; Talaat IM; Tan KK; Tbakhi A; Thiyagarajan A; Tiyuri A; Tovani-Palone MR; Unnikrishnan B; Vo B; Volovat SR; Wang C; Westerman R; Wickramasinghe ND; Xiao H; Yu C; Yuce D; Yunusa I; Zadnik V; Zare I; Zhang ZJ; Zoladl M; Force LM; Hugo FN
    JAMA Oncol; 2023 Oct; 9(10):1401-1416. PubMed ID: 37676656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the 8th edition of TNM staging of oral cancer with the 7th edition and its prognostic significance using clinical depth of invasion and extranodal extension.
    Yokota Y; Hasegawa T; Yamakawa N; Rin S; Otsuru M; Yamada SI; Hirai E; Ashikaga Y; Yamamoto K; Ueda M; Kirita T; Umeda M; Akashi M; Kurita H; Ohiro Y; Yanamoto S; Okura M
    Oral Oncol; 2023 Oct; 145():106519. PubMed ID: 37459802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting IL-6 trans-signalling: past, present and future prospects.
    Rose-John S; Jenkins BJ; Garbers C; Moll JM; Scheller J
    Nat Rev Immunol; 2023 Oct; 23(10):666-681. PubMed ID: 37069261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why C-reactive protein is one of the most requested tests in clinical laboratories?
    Plebani M
    Clin Chem Lab Med; 2023 Aug; 61(9):1540-1545. PubMed ID: 36745137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III study.
    Psyrri A; Fayette J; Harrington K; Gillison M; Ahn MJ; Takahashi S; Weiss J; Machiels JP; Baxi S; Vasilyev A; Karpenko A; Dvorkin M; Hsieh CY; Thungappa SC; Segura PP; Vynnychenko I; Haddad R; Kasper S; Mauz PS; Baker V; He P; Evans B; Wildsmith S; Olsson RF; Yovine A; Kurland JF; Morsli N; Seiwert TY;
    Ann Oncol; 2023 Mar; 34(3):262-274. PubMed ID: 36535565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Pack-Years of Cigarette Smoking With Survival and Tumor Progression Among Patients Treated With Chemoradiation for Head and Neck Cancer.
    Ma SJ; Yu H; Yu B; Waldman O; Khan M; Chatterjee U; Santhosh S; Gill J; Iovoli AJ; Farrugia M; Shevorykin A; Carl E; Wooten K; Gupta V; McSpadden R; Kuriakose MA; Markiewicz MR; Al-Afif A; Hicks WL; Platek ME; Seshadri M; Sheffer C; Warren GW; Singh AK
    JAMA Netw Open; 2022 Dec; 5(12):e2245818. PubMed ID: 36480200
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.